Recently, China's first anti-new crown virus special drug has been approved by the Food and Drug Administration. Professor Tsinghua, the leader of the research and development team, explained the principle of anti-covid-19 special drugs: antibodies are the natural weapons of the human body, they "find a needle in a haystack", screen out two antibodies with strong blocking power against the new crown virus, and let them play a combination punch together.
"The drug is infused intravenously and takes effect immediately after infusion into the body", which can reduce the hospitalization rate and mortality rate of high-risk COVID-19 outpatients by 80%, and the main role is mainly treatment. At the same time, antibodies can remain in the human body for 9 to 12 months, which also has a certain effect on preventing infection. This is currently the best treatment data among the anti-coronavirus drugs in the world.
Can this special medicine in China cope with "Omi Kerong"?
Zhang Linqi: Whenever a new variant strain appears, we have to go through the process of synthesis and evaluation every time, and we find that one of the antibodies of the combination fist is to maintain the activity, and the other antibody loses some of the activity, but because we are the combination fist, the two antibodies added together, still maintain the neutralization ability of the "Omikerong" variant strain, so we have great confidence in the inhibition ability of our antibody drugs against the newly emerging virus.
Source: Figureworm
Source: Synthesized from CCTV News, Surging News
![Evening News| the country's first infusion medical waste sorting robot was put into service| and chongqing's first traditional Chinese medicine children's fever clinic was put into use[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)